Latest Biotech News

Promising research spans biomaterial development to reverse heart aging by modulating extracellular matrix properties, and drone technology equipped with AI gas sensors to enable rapid detection...

Year-to-date biopharma financing continues robustly with significant funds raised in both public and private rounds, reflecting sustained investor interest despite industry layoffs. Market...

Sarepta Therapeutics has suspended Elevidys shipments for non-ambulatory Duchenne muscular dystrophy patients following a second acute liver failure death. Both fatalities involved boys reliant on...

Anne Wojcicki, co-founder and former CEO of 23andMe, through her nonprofit TTAM Research Institute, has won a bidding war to purchase most of 23andMe’s assets for $305 million. This new agreement...

Recent studies illuminate Parkinson’s disease pathology through peripheral nervous system insights and brain fluid dynamics. One cohort study detailed structural and functional alterations in...

The FDA has approved pembrolizumab as a perioperative treatment for patients with resectable locally advanced head and neck squamous cell carcinoma expressing PD-L1. The decision follows the phase...

Bristol Myers Squibb has appointed Dr. Chris Shibutani, a physician and former senior biotech analyst at Goldman Sachs, as EVP and chief strategy officer. Shibutani's role will encompass long-term...

Multiomics integration is advancing, particularly via strategic partnerships rather than in-house development. Ultima Genomics collaborates with Olink Proteomics to merge sequencing with...

Marking 25 years since the first draft announcement, leaders including Francis Collins and J. Craig Venter reflect on the landmark Human Genome Project (HGP). Collins applauds the global...

KalVista Pharmaceuticals announced that the FDA postponed its regulatory decision on the company’s on-demand oral therapy for hereditary angioedema. The delay is attributed to the agency’s heavy...

UC San Diego engineers developed a fiber membrane that removes heat via passive evaporation for cooling electronics and data centers. Published in Joule, this method offers a low-energy...

Researchers at the National University of Singapore engineered DECIPHER, a hybrid biomaterial mimicking heart extracellular matrix properties to study ageing effects. Their work reveals that...

Sarepta Therapeutics halted its Duchenne muscular dystrophy gene therapy Elevidys shipments for non-ambulatory patients after a second death from acute liver failure. Both fatalities occurred in...

Anne Wojcicki, co-founder and former CEO, successfully led a nonprofit bidding team to acquire 23andMe’s assets for $305 million, outbidding Regeneron. The deal includes strong commitments to...

KalVista Pharmaceuticals announced an FDA delay in its oral on-demand hereditary angioedema drug approval due to agency resource constraints. The postponement disrupts the company's development...

Sarepta Therapeutics has suspended shipments of its gene therapy Elevidys for Duchenne muscular dystrophy in non-ambulatory patients following a second fatal case of acute liver failure. Both...

The FDA approved pembrolizumab for patients with resectable locally advanced head and neck squamous cell carcinoma expressing PD-L1 (CPS ≥1), based on the pivotal KEYNOTE-689 phase 3 trial....

Anne Wojcicki's TTAM Research Institute won a $305 million bidding war to acquire most assets of 23andMe, surpassing Regeneron’s $256 million offer. The agreement preserves strong consumer privacy...

Researchers from Boston Children’s Hospital and Harvard Medical School developed a rapid, defined method to create functional vascular organoids by simultaneously activating endothelial and mural...

University of Michigan scientists performed the first quantum-mechanical simulations to explain the fundamental stability of quasicrystals, solids exhibiting non-repeating atomic lattices and...